General Announcement::Update on Board Meeting

Issuer & Securities

Issuer/ Manager: GLENMARK PHARMACEUTICALS LIMITED
Securities: GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security: No

Announcement Title: General Announcement
Date &Time of Broadcast: 27-May-2019 14:38:43
Status: New
Announcement Sub Title: Update on Board Meeting
Announcement Reference: SG190527OTHRJSTS
Submitted By (Co./ Ind. Name): Glenmark Pharmaceuticals Limited
Designation: Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below): This is to inform you that the meeting of the Board of Directors of the Company scheduled on Wednesday, 29 May, 2019, will consider, apart from audited financial result and declaration of dividend, also consider the proposal to enable raising of funds through issue of debt securities whether denominated in Indian Rupee and/or foreign currency(ies) either by way of a public issue or by way of a private placement in accordance with the provisions of the applicable law, subject to necessary approvals, if any. Proceeds from these debt securities issuance will be used mainly to refinance existing debt.

Please treat this as the intimation required under Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

Total size =886K